Biomerica is a global biomedical technology company that specializes in the development, patenting, manufacturing, and marketing of advanced diagnostic and therapeutic products. With a passion for improving the quality of life, their products are designed to detect diseases early and guide therapy, ultimately enhancing the health and well-being of individuals while reducing healthcare costs. Their primary focus is on gastrointestinal and inflammatory diseases, and they have a wide range of diagnostic and therapeutic products in clinical studies.

Biomerica's in-vitro diagnostics are used worldwide for screening and detecting high prevalence chronic medical conditions and diseases, particularly in the field of gastrointestinal and inflammatory diseases. One of their notable innovations is the inFoods IBS test, which uses a simple blood test to decipher which foods trigger symptoms of irritable bowel syndrome (IBS). This breakthrough technology offers valuable insights for physicians and patients in managing and treating IBS.

With over 40 million IBS patients, 100+ patents filed, and 80+ diagnostic products, Biomerica is committed to advancing diagnostic solutions and improving healthcare outcomes. They have also been featured in reputable news outlets such as NBC, CBS, and ABC